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Trends Box 
x Marrow adipose tissue (MAT) is dynamically regulated in metabolic diseases 
including diabetes, obesity, and anorexia, and by pharmacotherapies including 
estrogen, growth hormone, and glucocorticoids.  
x MAT is an endocrine organ that during caloric restriction can contribute to 
circulating adipokines, such as adiponectin. 
x MAT exists in two forms, regulated and constitutive. Regulated and constitutive 
marrow adipocytes are defined based on their surrounding microenvironment 
and response to external stimuli. They have distinct developmental patterns, 
adipocyte size, lipid saturation, and transcription factor expression.  
x The fold-increase of MAT in rodent models of metabolic diseases such as 
diabetes and obesity exceeds what is observed in humans. The persistence of 
MAT adipocytes after their formation is also significantly reduced in mice.   
 
Trends Box
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Glossary  35 
Adiponectin: A secreted adipocyte-derived hormone that is produced by both marrow and 36 
white adipose tissues. Has the potential to regulate metabolic and cardiovascular health. 37 
Brown adipose tissue (BAT): a distinct type of adipose tissue found in mammals that is 38 
specialized for mediating non-shivering thermogenesis. 39 
Constitutive marrow adipose tissue (cMAT): a subtype of marrow adipocytes found in the 40 
yellow bone marrow that develops early in life, primarily in the distal regions of the skeleton.  41 
Lineage tracing: is a technique used for the identification of progeny of a single cell; single cells 42 
and their progeny are marked based on expression of fluorescent proteins (ex. tdTomato and 43 
eGFP) in vivo.  44 
mT/mG: A lineage tracing system in which all cells constitutively express a floxed, membrane-45 
targeted tdTomato (mT) cassette. When exposed to CRE-recombinase, generally expressed 46 
under the control of a genetic promoter, the tdTomato cassette is excised allowing the cells to 47 
express eGFP. This switches the color of the cells within the traced lineage from ‘red’ to ‘green’.   48 
Myogenic factor 5 (Myf5): a transcriptional activator that promotes transcription of muscle-49 
specific target genes. The Myf5 promoter has also been used to genetically trace BAT 50 
adipocytes, and a subset of WAT, based on its expression in their progenitor cells.  51 
Osmium tetroxide staining: a method by which radio-dense osmium is incorporated into the 52 
lipid droplet of the marrow adipocyte. The stained adipocytes are then visualized in three-53 
dimensions using high-resolution computed tomography. 54 
Osterix (Osx): a transcriptional activator that is essential for osteoblast differentiation. The 55 
osterix promoter is expressed by skeletal mesenchymal precursor cells and can be used to 56 
genetically trace osteoblasts and MAT adipocytes.  57 
Positron emission tomography - computed tomography (PET/CT): a radiological technique that 58 
uses a specialized camera to detect and image radioactive tracers within the body. This 59 
information is then overlaid on the three-dimensional CT scan to pinpoint the exact anatomic 60 
location of the tracer. 61 
Regulated marrow adipose tissue (rMAT): A subtype of marrow adipocytes found within the 62 
red, blood-cell forming portions of the bone marrow.  63 
White adipose tissue (WAT): a metabolically active endocrine organ found in discrete depots  64 
and specialized to store excess energy as triacylglycerols, and release fatty acid (FA)s and 65 
glycerol when energy expenditure exceeds energy intake. 66 
 67 
 68 
 69 
 70 
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Abstract  71 
Marrow adipose tissue (MAT) is a unique fat depot, located in the skeleton, that has the 72 
potential to contribute to both local and systemic metabolic processes. In this review we 73 
highlight several recent conceptual developments pertaining to the origin and function of MAT 74 
adipocytes; consider the relationship of MAT to beige, brown, and white adipose depots; 75 
explore MAT expansion and turnover in humans and rodents; and discuss future directions for 76 
MAT research in the context of endocrine function and metabolic disease. MAT has the 77 
potential to exert both local and systemic effects on metabolic homeostasis, skeletal 78 
remodeling, hematopoiesis, and development of bone metastases. The diversity of these 79 
functions highlights the breadth of MAT’s potential impact on health and disease. 80 
 81 
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Bone marrow adipose tissue; does it matter? 92 
Research on white and brown adipose tissues (WAT and BAT respectively, see glossary) has 93 
accelerated in recent years in response to the rising incidence of obesity in most developed 94 
nations [1]. Perhaps coincidentally, there has been a resurgence in the study of the adipose 95 
tissue within the skeleton [2]. Our knowledge of this so-called marrow adipose tissue (MAT) 96 
generally lags behind that of the other adipose depots. In this review we summarize MAT 97 
composition and variation between species and place it within the context of the other adipose 98 
tissues. We also explore MAT’s endocrine and paracrine secretory properties, and expansion 99 
and regulation in metabolic disease. Lastly, we propose future directions for MAT research in 100 
the context of endocrine function and metabolic disease.  101 
 102 
MAT composition and distribution 103 
Marrow adipose tissue formation begins at or slightly before birth at distal skeletal sites 104 
including the tail, hands, and feet in mice and humans (reviewed in [2]). This pattern of early 105 
fatty marrow conversion in the distal skeleton in conserved in vertebrate species including 106 
mice, rats, rabbits, and humans. After this initial change, marrow adipocytes continue to form 107 
throughout life in areas of hematopoietic marrow [3]. MAT that is concentrated in the distal 108 
skeletal gives this bone marrow its characteristic ‘yellow’ appearance [4] and is referred to as 109 
constitutive MAT (cMAT) [5]. The ‘red’ marrow in regions including the lumbar/thoracic 110 
vertebrae, proximal limb skeleton, hip and ribs contains the majority of the hematopoietic cells, 111 
but can still retain a high volumetric proportion of adipocytes [2,6], known as regulated MAT 112 
(rMAT) (Box 1). Historic observations in rabbits [7] and humans [3,8] and recent work in mice 113 
[5] and rabbits [4] support the concept that MAT undergoes differential development and 114 
regulation depending on where it is located in the skeleton [5].  115 
Regional differences have been observed between rMAT and cMAT (Box 1). Experiments in 116 
mice and/or rats have shown that rMAT adipocytes preferentially develop within the red 117 
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marrow throughout life, are smaller in size (~31-33 µm diameter), contain more saturated lipids 118 
and express lower levels of the adipogenic transcription factors Cebpa and Cebpb. Conversely, 119 
cMAT adipocytes develop shortly after birth, are larger in size (~38-39 µm diameter), contain 120 
more unsaturated lipids, and have elevated Cebpa and Cebpb [4,5]. Regulated MAT lipid 121 
saturation and expression of adipocyte genes is reminiscent of WAT – thus the critical 122 
comparison is that cMAT has elevated expression of these genes and increased lipid 123 
unsaturation relative to rMAT or WAT depots.  124 
Based on histology and gross anatomic assessment of human specimens, roughly 70% of the 125 
adult bone marrow volume is MAT [2,3]. Total marrow volume is, on average, 1632+/-587 cm3 126 
based on whole body assessment with PET/CT [9]. Combined, this would predict 1142+/-410 127 
cm3 of total MAT, equivalent to 1.03+/-0.37 kg (fat density = 0.9 g/cm3).  Indirect MRI-based 128 
techniques concur, revealing that the amount of total MAT in the skeleton of an average size 129 
human is ~1.35 kg (ranging from 0.5 to 3 kg) [8,10,11], accounting for approximately 8% of total 130 
fat mass. Depending on peripheral fat volume, this proportion can range from as low as 1% to 131 
as high as ~30% [2,12]. One can therefore speculate that the average human skeleton contains 132 
enough MAT to directly influence local and systemic metabolic processes, and that the balance 133 
between total WAT and MAT volume has the potential to contribute to these relationships. 134 
MAT volume varies between species 135 
As a general rule, the MAT content, by percent volume, in the red marrow is directly 136 
proportional to the size of the animal (i.e. humans > rabbits > rats > mice) [2]. Mice have a 137 
significantly reduced proportion of MAT in areas of red marrow, as quantified in three-138 
dimensions using osmium tetroxide staining combined with micro-computed tomography 139 
[5,8,12,13]. For example, 12-week-old C57Bl/6J (B6) male mice have on average 0.7% MAT by 140 
volume in the bone marrow of the tibial diaphysis [5]. MAT content and its distribution also 141 
vary between mouse strains. For example, the  proximal tibial MAT in C3H/HeJ mice is 12.7-fold 142 
higher than B6 mice at 12-weeks of age, though the total tibial MAT volume is only increased by 143 
1.7-fold [5]. This is explained by increased MAT storage in the distal tibia of B6 mice. In humans, 144 
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based on biopsies of the iliac crest, the amount of MAT in the red marrow is roughly 145 
proportional to the age of the patient (i.e. 30 years old = 30% MAT; 70 years old = 70% MAT) 146 
[14]. Though both observations follow the well-documented increase in MAT with age [3], the 147 
absolute amount of MAT varies considerably. This may have important implications for the 148 
relationship of MAT to surrounding tissues. For example, during caloric restriction (CR) in mice, 149 
tibial MAT volume expands to 40% of diaphyseal volume; however, when this MAT expansion 150 
was limited to only 15%, systemic adaptations to CR were impaired [12]. Systemic effects of 151 
MAT may therefore occur only when MAT volume surpasses a critical threshold, in which case 152 
even a 17-fold increase in tibial MAT volume in an aged B6 mouse may not result in a 153 
detectable metabolic or skeletal phenotype (e.g. insulin resistance or bone loss). In contrast, 154 
the ~2.3-fold increase from 30% to 70% MAT in the red marrow of humans with age, or the 155 
reported 1.3-fold increase with anorexia, may be more likely to achieve ‘critical mass’ with 156 
significant downstream consequences in humans, including contributions to bone turnover and 157 
metabolic adaptation of peripheral tissues [2,12]. 158 
It is currently unknown whether the decreased MAT within the red marrow of small animals 159 
such as mice means that the proportion of total MAT relative to peripheral WAT is also lower. 160 
Rodents, unlike humans, have a tail, the vertebrae of which are filled almost completely with 161 
MAT [5,15]. This may compensate for the decrease in MAT at other sites and warrants further 162 
characterization. Until this is clarified, it is worth keeping in mind that MAT-related findings in 163 
rodents may become more significant in larger species with greater MAT volume (such as 164 
humans) or in conditions of marked MAT expansion (such as CR), especially in the red marrow.  165 
MAT versus other adipose tissues  166 
Examination of marrow fat in the context of the rapidly expanding literature on adipose tissues 167 
provides clues about its function. Current classifications include white, brown, beige/brite, and 168 
more recently even lactation-associated ‘pink’ adipocytes [16,17]. Where does MAT fall on this 169 
spectrum – if at all (Figure 1)?  170 
Formation 171 
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Adipocytes are formed after differentiation of their progenitor cells. The complexities of the 172 
WAT progenitor have been reviewed previously [18].  Like WAT, MAT preadipocytes gradually 173 
accumulate lipid that coalesces into a unilocular droplet and displaces the nucleus and 174 
cytoplasm peripherally [19]. Electron microscopy suggests that the ‘fibroblast-like’ WAT 175 
progenitors have dense profiles of rough endoplasmic reticulum (ER) and are closely-associated 176 
with collagen fibers [19–21]. Though MAT progenitors may contain occasional rough-ER 177 
profiles, they are not associated with collagen. When compared to mature BAT adipocytes 178 
using EM, MAT generally lacks glycogen and has reduced mitochondrial content [19]. Lineage 179 
tracing in ‘mT/mG’ mice has also been used to characterize the origins of the MAT adipocyte. 180 
These mice constitutively express a floxed, membrane-targeted tdTomato cassette (mT) 181 
upstream of an eGFP cassette (mG). When cre-recombinase is expressed, mT is excised allowing 182 
expression of the membrane-targeted eGFP. Unlike gonadal WAT and intramuscular fat, MAT 183 
adipocytes are uniformly traced in Osterix-cre:mT/mG mice [22] (Figure 1). These 184 
ultrastructural and lineage tracing findings suggest that MAT adipocytes are derived from a 185 
unique progenitor cell that is distinct from that of WAT and BAT.  186 
 187 
A proportion of the developing MAT adipocytes are closely associated with the endothelium of 188 
the marrow sinuses [19]. These progenitors may have a shared identity with perivascular 189 
CXCL12-abundant reticular (CAR) cells and/or Nestin+ mesenchymal stem cells [23,24]. 190 
However, it remains unknown whether they are distinct in origin and/or function from 191 
adipocytes that develop near the endosteal surface of the bone. There is recent evidence, for 192 
example, that distinct waves of embryonic and adult Osterix+ progenitor cells organize the 193 
developing bone and marrow [25]. Additional experiments have revealed that LepR+ 194 
perisinusoidal cells give rise to adult, but not developmental, osteo-adipogenic lineages [26]. 195 
Both LepR+ and Osterix+ progenitor cells contribute to irradiation-induced MAT expansion [25]. 196 
In contrast, Grem1 identifies a population of osteochondroreticular cells near the growth plate 197 
and trabecular bone that can give rise to osteoblasts, but not adipocytes [27]. In WAT, 198 
adipocyte progenitors that promote homeostasis of the adult WAT are lineage positive for 199 
smooth muscle actin and reside in a perivascular niche [28]. In contrast, progenitors responsible 200 
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for initial WAT organogenesis lack a vascular niche and are negative for smooth muscle actin 201 
[28]. Like these skeletal and WAT-progenitors, MAT subpopulations may be derived from 202 
multiple types of precursor cells (e.g. endosteal vs perivascular, tissue development vs 203 
maintenance, etc). Clarification of the identity of the MAT progenitor, or progenitors, will be 204 
necessary to accurately model the nuances of MAT development and function both in vitro and 205 
in vivo. 206 
 207 
Characterization 208 
It has been proposed that MAT is ‘beige’ or ‘brown-like’ in character (Box 2). BAT adipocytes 209 
function to convert stored energy into heat. They have a multilocular lipid droplet, express UCP-210 
1, and the majority of cells are derived from a Myf5+ progenitor [16,29]. Though Myf5 is 211 
thought to be a BAT-specific lineage marker, it also traces unilocular adipocytes within the 212 
anterior subcutaneous WAT and the retroperitoneal WAT [29]. Beige/brite adipocytes are 213 
derived from a subset of pre-existing cells within the WAT that can be reversibly differentiated 214 
into ‘brown-like’ multilocular cells that express UCP-1 [30–33]. Adult MAT is not histologically 215 
[2] or ultrastructurally [19] similar to traditional BAT. However, there has been one published 216 
image of several UCP-1+, BAT-like cells in the lumbar vertebral marrow of a young 3-week-old 217 
mouse [34]. These reported BAT-like cells may be distinct from unilocular, adult MAT. The 218 
concept of a beige-like unilocular MAT adipocyte is attractive, with proposed functional 219 
implications [35]. However, the interpretation of current research is limited by the technical 220 
challenges of working with MAT; hence, more work is clearly needed to explore this possibility 221 
(Box 2).   222 
 223 
Function 224 
Unlike WAT, which can increase seemingly without limit, MAT is constrained spatially within the 225 
boundaries set by the skeleton. MAT adipocytes are also situated in a unique 226 
microenvironment, surrounded by hematopoietic and skeletal lineage cells. This likely 227 
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contributes to its differential regulation and points to the local microenvironment, in addition 228 
to endocrine mediators, as a major regulators of MAT function.   229 
WAT is the primary site for long-term storage of excess energy and, as a consequence, is tightly 230 
controlled in response to whole-body energy balance (see [16] for review). Energy storage by 231 
WAT is principally regulated by insulin, which promotes glucose and lipid uptake while 232 
inhibiting lipolysis. Current evidence suggests that MAT expresses components of the insulin 233 
signaling machinery [36]. MAT also responds positively to rosiglitazone, a thiazolidinedione, by 234 
inducing genes involved in insulin signaling, fatty acid and carbohydrate metabolism [36,37]. 235 
Thus, like WAT, is MAT used for energy storage and mobilization? When the current evidence is 236 
considered, the results are puzzling. For example, the observation that both CR [12,38] and 237 
high-fat diets [39] can increase skeletal MAT in mice is counterintuitive if the role of MAT, like 238 
WAT, is dynamically related to systemic energy demands. Recent work suggests that increased 239 
MAT with CR is due to expansion of adipocyte numbers through adipogenesis rather than 240 
increases in adipocyte size, which may further disassociate MAT and energy metabolism [4,12]. 241 
Accumulation of MAT in mouse models of T1DM also demonstrates that hypoinsulinemia is 242 
insufficient to block MAT expansion [40].  243 
It may be that some MAT adipocytes are linked to systemic energy demand while others 244 
provide support for surrounding cells. For example, MAT may serve as a lipid reservoir, a 245 
storage site for ectopic lipid that protects skeletal osteoblasts from lipotoxicity [41]. The liver 246 
and skeletal muscle, for example, efficiently store lipid in times of excess circulating triglyceride 247 
[42]. This also prompts the question – are all MAT-appearing cells within the bone marrow 248 
actually adipocytes? Expression of key adipogenic transcription factors Pparg, Cebpa, and 249 
Cebpb in isolated MAT cells from healthy animals supports this identity [5,43]. However, the 250 
storage of marrow lipid in non-MAT populations, especially in states of disease, has not been 251 
thoroughly explored.  252 
MAT may function to provide support to surrounding cells and tissues. For example, there is 253 
evidence that MAT may contribute to the mechanical properties of the skeleton [44,45] (Figure 254 
1). MAT is also intimately associated with the blood-forming marrow. Primary human MAT 255 
 10 
 
adipocytes, purified from the iliac crest, have the ability to support differentiation of CD34+ 256 
hematopoietic progenitor cells in vitro [43]. However, in vivo evidence in mice suggests that 257 
MAT adipocytes are predominantly negative regulators of the hematopoietic 258 
microenvironment, inducing both quiescence and loss of progenitor cells [15]. Indeed, genetic 259 
or pharmacologic inhibition of MAT expansion enhances hematopoietic engraftment and 260 
recovery after irradiation and bone marrow transplant in mice [15]. It remains unclear whether 261 
MAT is always a negative component of the hematopoietic niche. For example, 262 
thiazolidinedione (TZD)-induced MAT expansion in mice did not alter hematopoietic progenitor 263 
frequency within the bone marrow in vivo [46]. Future work is needed to extend these studies 264 
and to determine if MAT can serve as a supportive member of the niche or an energy source for 265 
hematopoietic differentiation in some contexts (Figure 1). 266 
 267 
MAT as a secretory tissue 268 
The secretion profile of MAT and its functional endocrine and paracrine implications remain 269 
largely unexplored. MAT secreted factors have been analyzed in conditioned media from three 270 
types of cell preparations: isolated bone mesenchymal stem cells (BMSCs) that are 271 
differentiated to adipocytes (in vitro), primary MAT adipocytes purified by collagenase digestion 272 
(ex vivo), and whole MAT tissue explants (explant).  Each method has limitations. In vitro 273 
models lack micro-environmental programming during differentiation and often rely on potent 274 
adipogenic stimulants such as TZDs, which can independently regulate MAT [47]. Ex vivo 275 
analysis of primary adipocytes overcomes these limitations, but chemical processing and loss of 276 
surrounding microenvironmental signals can limit interpretation of results. Explants maintain 277 
MAT adipocytes in their native microenvironment but are complicated by heterogeneity and 278 
cell breakdown. Future comparison and utilization of multiple techniques will help to accurately 279 
refine MAT’s secretory properties.       280 
In vitro, human adipocytes derived from sternal BMSCs secrete the cytokines IL-6, MIP-1α, G-281 
CSF, and GM-CSF [48]. In mice, in vitro BMSC-derived adipocytes also produce CXCL1 and CXCL2 282 
[49]. Ex vivo primary human MAT adipocytes from the iliac crest also secrete detectable levels 283 
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of IL-6 and G-CSF, in addition to IL-8, after 7-days of ceiling culture [43]. It has been proposed 284 
that secretion of cytokines by MAT stimulates local differentiation and activation of osteoclasts 285 
[49]. This suggests that, at least in some contexts, MAT may promote increased bone 286 
remodeling - contributing to osteoporotic bone loss and even bone destruction in the setting of 287 
skeletal metastasis [49] (Figure 1).   288 
MAT adipocytes also secrete adipokines such as leptin (in vitro) [50] and adiponectin (explant) 289 
[12]. Paradoxically, CR in rodents and humans causes elevation of circulating adiponectin 290 
despite loss of WAT [12]. However, CR also drives MAT expansion [4,12,38]. To determine 291 
whether MAT contributes to circulating adiponectin with CR, MAT expansion was inhibited by 292 
overexpressing the Wnt10b transgene from the osteocalcin promoter in mice (OCN-Wnt10b) 293 
[12]. Inhibition of MAT expansion was sufficient to suppress CR-associated 294 
hyperadiponectinemia [12]. Similarly, in rabbits, neither MAT expansion nor 295 
hyperadiponectinemia occured during moderate- or extensive-CR, despite loss of WAT [4]. 296 
These results demonstrate that CR-induced MAT expansion is necessary for maximal increases 297 
in circulating adiponectin. These observations support the ability of MAT to function as an 298 
endocrine organ in the context of CR. While further research is needed, these studies also 299 
revealed that impaired MAT expansion and/or hyperadiponectinemia is associated with blunted 300 
induction of Pgc1a, Tfam and Acadm in skeletal muscle during CR in OCN-Wnt10b mice [12], 301 
further implying that MAT may contribute to skeletal muscle adaptation during CR and 302 
suggesting that, as an endocrine organ, MAT can exert systemic effects.  303 
 304 
Endocrine regulation of MAT expansion in metabolic disease 305 
As with CR in humans and mice, MAT expansion is a common response to many clinical 306 
conditions and pharmacotherapies, including diabetes, obesity, anorexia, aging, estrogen 307 
deficiency and glucocorticoid use (Table 1). In general, MAT expansion can occur through 308 
increases in cell number and/or cell size [51]. Though MAT can contribute to skeletal muscle 309 
adaptation with CR [12], it remains unclear whether MAT accumulation is uniformly beneficial. 310 
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Alternatively, it might be a passive, inconsequential phenomenon, or a pathological response 311 
that negatively impacts local or systemic health [52]. For example, MAT formation and bone 312 
loss are often inversely associated, though this relationship remains unclear despite significant 313 
research efforts over the last 30 years (reviewed in [53]) (Figure 1). The relationship between 314 
MAT and metabolic health remains almost entirely unknown. 315 
The fold-increase of MAT in rodent models of metabolic disease generally exceeds what is 316 
observed in humans. In mice with type 1 diabetes mellitus (T1DM), MAT selectively increases in 317 
the appendicular, but not axial, skeleton [40,54]. In contrast, neither MAT loss nor gain has 318 
been observed in humans with T1DM [54] (Table 1). In rodent models of T2DM, such as the 319 
ob/ob mouse, a significant increase in MAT occurs [55]. However, in humans with type 2 320 
diabetes, only a slight increase (or no change) in MAT has been reported [53,56]. Similar results 321 
have been noted with obesity in which MAT expansion is much more dramatic in mice fed a 322 
high-fat diet when compared to obese humans [39,57,58]. The diminished expansion of MAT in 323 
humans, relative to rodents, may be related to the higher baseline MAT content of human 324 
marrow. Once formed, MAT is also more persistent in humans than in mice – lasting for years 325 
after prolonged bed rest or radiation therapy [59,60]. This is also true for WAT adipocytes, 326 
which have an estimated lifespan of 10-years in humans [61] but less than 1-year in mice [62]. 327 
The implications of these differences are unknown, though recent work has shown that 328 
increases in MAT lipid saturation are related to fracture risk in postmenopausal women with 329 
T2DM [63]. Thus it may be the quality, rather than the quantity, of MAT that contributes to 330 
skeletal fragility and metabolic adaptation in humans. 331 
There are many local and systemic factors with the potential to regulate MAT formation and 332 
function, thereby contributing to MAT expansion. For example, there is emerging clinical 333 
evidence that MAT formation is driven by increases in circulating lipids such as triglycerides 334 
[54,64]. Thus, inhibition of elevated serum lipid levels (ex. treatment with statins) could 335 
potentially decrease MAT.  336 
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Endocrine factors also contribute to the balance between formation of new MAT cells through 337 
adipogenesis and turnover of mature MAT adipocytes by lipolysis or apoptosis (Figure 1). 338 
Pituitary-derived growth hormone, for example, actively suppresses MAT expansion [65]. 339 
Specifically, removal of the pituitary gland in rats causes robust increases in MAT that are 340 
rescued by administration of exogenous growth hormone, but not intermittent PTH, 17β-341 
estradiol, or IGF-1 [65]. Estrogen deficiency [66,67], FGF-21 [68] and glucocorticoids [69,70] also 342 
promote MAT formation. Of these, increases in circulating glucocorticoids may be necessary for 343 
MAT accumulation with CR [4].   344 
Several other endocrine factors have been postulated to regulate MAT formation. Notable 345 
among these is leptin, with hypoleptinemia suggested to promote MAT expansion. Indeed, 346 
pituitary excision in rats [65] and WAT loss with CR in mice [4] can both lead to decreased 347 
circulating leptin and increased MAT formation. Conversely, direct administration of leptin into 348 
the intracerebroventricular (ICV) space leads to profound MAT loss in mice and rats [71–73]. 349 
These effects, however, require administration of supra-physiological doses of leptin [74], and it 350 
remains unclear if changes in leptin concentrations, within physiological limits, are sufficient to 351 
impact MAT turnover. For example, estrogen deficiency is associated with increases in MAT 352 
despite increases in circulating leptin [75,76], demonstrating that increased leptin per se is not 353 
sufficient to ablate MAT. In contrast, CR in rabbits leads to hypoleptinemia without MAT 354 
expansion, while in female mice CR leads to MAT expansion without causing hypoleptinemia 355 
[4]. Together, these observations suggest that hypoleptinemia is neither sufficient nor 356 
necessary for MAT expansion. When administered peripherally, elevated circulating leptin may 357 
inhibit MAT progenitor differentiation [77]. In addition, both ICV and peripheral administration 358 
likely cause sustained activation of the sympathetic nervous system (SNS) [78]. Sympathetic 359 
drive coordinates metabolic responses to energy deficits with respect to nutrient partitioning, 360 
release, and utilization [16]. Activation of the SNS could promote local release of 361 
norepinephrine and induction of lipolysis in mature MAT adipocytes through β-adrenergic 362 
receptors. There is also evidence that leptin-induced loss of MAT can occur through apoptosis 363 
[55,71] (Figure 1).  364 
 14 
 
With the exception of certain lipodystrophies, MAT is either retained or increased in metabolic 365 
diseases including diabetes, obesity, anorexia, and gonadal dysfunction (Table 1). MAT 366 
expansion is dynamically regulated by endogenous circulating endocrine factors such as growth 367 
hormone, estrogen, and glucocorticoids and is also readily modified by pharmacotherapies that 368 
impact any of these systems. However, despite its prevalence, the role of MAT expansion in 369 
metabolic disease remains relatively unknown.  370 
 371 
Concluding Remarks and Future Perspectives 372 
As a field, we know the location of the MAT and how much of it we have. This has been aided 373 
by the development and refinement of skeletal imaging techniques in rodents [13] and humans 374 
[10,79,80]. We also know how MAT changes with a relatively large variety of systemic 375 
conditions and medications (Table 1); that relative MAT volume and expansion differ between 376 
rodents and humans; that MAT behaves differently depending on where we look in the 377 
skeleton (e.g. rMAT vs cMAT); and that MAT is capable of secreting endocrine factors, such as 378 
adiponectin. However, many questions remain (see outstanding questions box).  379 
It is unknown whether MAT can become dysfunctional or unhealthy, or whether certain types 380 
of MAT adipocytes are more likely to have deleterious effects [35,81]. In humans in particular, it 381 
may be the quality rather than the quantity of marrow fat that matters [63]. For example, MAT 382 
lipid saturation, rather than total MAT, is a novel biomarker of skeletal fragility in diabetes [63]. 383 
This is particularly intriguing since rMAT is defined, in part, by its increased lipid saturation 384 
relative to cMAT [5]. Regarding dysfunction, gene expression in isolated B6 mouse MAT 385 
adipocytes suggests potential for mitochondrial dysfunction and altered fatty acid synthesis 386 
with aging [82]. Similar analyses in whole tibiae from B6 mice reveal age-related decreases in 387 
BAT-marker genes Prdm16, FoxC2, Adrb3, and Dio2 that may also indicate a shift in the nature 388 
of the MAT adipocyte [47].    389 
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Quantitative analysis of the metabolic processes occurring within the MAT adipocytes (e.g. lipid 390 
synthesis, uptake, turnover and breakdown) in response to local and systemic stimulants will be 391 
necessary to place MAT into the context of whole-body energy balance. To do this the field will 392 
need to establish standardized protocols for molecular analysis of MAT in order to produce 393 
meaningful comparisons between adipocyte subpopulations across species and strains of 394 
animals.  395 
Future work is also needed to identify the mechanisms underlying MAT expansion and to 396 
characterize its benefits or consequences in metabolic disease states. In the context of 397 
hematopoiesis, ablation of MAT promotes hematopoietic recovery post-irradiation [15]. 398 
However, more MAT isn’t necessarily a bad thing. For example, increases in MAT with CR 399 
promote metabolic adaptation [12]. In addition, the cMAT-rich distal tibia, despite being nearly 400 
filled with adipocytes, actually has more trabecular bone with increased mineral density 401 
relative to the proximal tibia [83]. Metastasis of tumors to cMAT-rich areas is also very rare 402 
when compared to hematopoietic marrow [3]. In contrast, areas with rMAT can more readily 403 
undergo MAT accumulation, for example with HFD, which may promote prostate tumor 404 
progression by increasing osteoclast activity and bone turnover [49]. It will be important to 405 
consider MAT’s site-specific differences in future studies on the relationships between MAT, 406 
bone, hematopoiesis, and metabolism. In addition, it will be equally important to shift our focus 407 
away from what we know about WAT and toward what makes MAT unique in its own context 408 
and microenvironment to truly advance the field. 409 
 410 
 411 
 412 
 413 
 414 
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Box 1 – Regulated and constitutive marrow adipose tissue.  415 
Work by Tavassoli in 1976 identified a population of marrow adipocytes that were stable in 416 
response to phenylhydrazine, and another that was labile. He also observed differential staining 417 
of marrow adipocytes with performic acid Schiff (PFAS) [7]. Similar results were recently 418 
reported in the context of cold exposure, in which the adipocytes within the red marrow 419 
decrease in number and size while those within the yellow marrow do not [5,7]. Based on these 420 
results, single adipocytes interspersed within red marrow have been termed regulated marrow 421 
adipocytes (rMAT), and those within yellow marrow, constitutive (cMAT) (Figure IA-C) [5]. This 422 
may have a genetic basis, as knock-out of PTRF in mice, a model of congenital generalized 423 
lipodystrophy-4, results in selective loss of the rMAT, but not cMAT, adipocytes [5]. 424 
In addition to differences in regulation and development, rMAT and cMAT adipocytes are 425 
currently defined by their unique gene expression profile and lipid composition. Expression of 426 
Pparg is similar between rat rMAT and cMAT adipocytes, however, Cebpa and Cebpb are 427 
selectively elevated in cMAT – suggesting that these adipocytes may undergo alternative 428 
transcriptional regulation. Relative to rMAT and WAT, cMAT adipocytes also have increased 429 
lipid unsaturation, driven by decreases in palmitate and stearate and increases in their 430 
monounsaturated derivatives [5]. Indirect 1H-MRS analyses of the femur and tibia suggests that 431 
the same may be true in humans [5]. Future work is needed to refine the properties of rMAT 432 
and cMAT adipocytes and their conservation between species. 433 
Though we know that rMAT-like adipocytes are enriched in the proximal, hematopoietic 434 
skeleton and cMAT-like cells are enriched in the distal areas, there is possibility for both 435 
subtypes to exist in the same region [5]. In rabbits, for example, the adipocytes near the 436 
hematopoietically active, endocortical surface of the femur are PFAS-positive, while those 437 
clustered in the center of the femoral marrow are PFAS-negative [7]. Like this central core of 438 
femoral MAT, the cMAT adipocytes in the distal tibia are also PFAS-negative.  439 
There is much that remains unknown about rMAT and cMAT. Though they appear to be 440 
developmentally distinct, it is unclear whether they derive from distinct progenitors, or rather 441 
represent a different state of maturation of the MAT adipocyte from a common lineage. 442 
Identification of microenvironmental and cell-autonomous differences are needed to 443 
understand why rMAT is preferentially regulated. Lastly, we need to determine the impact of 444 
each subtype on bone loss and systemic metabolism in health and disease.   445 
 446 
 447 
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Box 2 – Is MAT beige or brown fat?  448 
It has been hypothesized that MAT has BAT-like characteristics. This is based on gene 449 
expression in whole tibia bones showing that BAT markers Prdm16, Dio2, FoxC2 and Pgc1α (but 450 
not Ucp1) are highly elevated relative to epididymal WAT (eWAT) and expressed at comparable 451 
levels to whole BAT - when normalized to the reference gene Fabp4/aP2 [47]. In a separate 452 
study, Fabp4 was expressed at only 2.4-4.3% of what is observed in eWAT [82]. Thus, its use as 453 
a normalization tool in a complex tissue such as the tibia may significantly elevate predicted 454 
gene expression. Indeed, expression of Prdm16, Pgc1α, and FoxC2 were not consistently 455 
elevated in purified MAT when compared to eWAT adipocytes from mice at 6-, 14-, and 18-456 
months of age [82]. Deiodinase2 (Dio2)-mediated thyroid hormone conversion from thyroxine 457 
(T4) to triiodothyronine (T3) has the potential to regulate adipose tissue thermogenesis. 458 
Expression of Dio2 was elevated by 237-fold in whole tibia when normalized to Fabp4/aP2 [47] 459 
and by 1.3- to 12.1-fold in isolated MAT adipocytes [82].  460 
Skeletal MAT volume is regulated by temperature [2,5], however, the ability of MAT adipocytes 461 
to undergo stimulated thermogenesis and produce heat is not known [36]. UCP-1 is the 462 
canonical regulator of thermogenic uncoupling [16]. Thus, it is worth noting that in both of the 463 
above studies Ucp1 expression was not elevated in MAT relative to eWAT at baseline [47,82]. 464 
However, treatment of B6 mice with rosiglitazone increased MAT and caused a 2- to 3-fold 465 
elevation of BAT-markers including Ucp1, Pgc1α, and Prdm16 [47]. PGC-1α regulates the 466 
expression of thermogenic genes in BAT, it also regulates mitochondrial biogenesis and 467 
oxidative metabolism in other cell types [84]. PRDM16 is a co-activator that promotes 468 
thermogenic gene expression and forms a complex with multiple adipogenic transcription 469 
factors, including PPARγ and PGC-1α [85]. Though interesting, use of the whole tibia makes 470 
these changes challenging to interpret [47]. In addition, it is unclear at what point Ucp1 471 
expression indicates uncoupling of respiration [86] and Ucp1 at the RNA level does not 472 
necessarily correlate with UCP-1 protein and adaptive thermogenesis [87]. For this reason 473 
analysis of intact MAT obtained from rabbits [4,12] or from isolated MAT adipocytes [5] might 474 
be preferable. While the concept of a BAT/beige-like MAT is intriguing, clearly more work is 475 
needed to definitively address this hypothesis and its implications. 476 
 477 
 478 
 479 
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Figure Legends 486 
BOX 1 Figure I. Regulated and constitutive marrow adipose tissue (MAT) in the mouse. (A) 487 
Proposed distribution of regulated MAT (rMAT) and constitutive MAT (cMAT) in the mouse 488 
skeleton when marrow is present. Regulated MAT is found in the more proximal regions 489 
including the mid- to proximal-tibia, femur, and lumbar vertebrae. Constitutive MAT is found in 490 
the most distal portion of the tibia and tail vertebrae. (B) Three-dimensional reconstruction of 491 
an osmium-stained mouse tibia. (C) Representative histology of rMAT and cMAT adipocytes 492 
within the bone marrow. 493 
 494 
Figure 1, KEY FIGURE. The knowns and unknowns of MAT. (A) Adipose tissue is typically 495 
classified as white, brown, or beige. Bone marrow adipocytes are morphologically similar to 496 
white adipocytes; however, it is unclear where they fall on this ‘white-beige-brown’ spectrum, if 497 
at all. (B) Lineage tracing studies demonstrate that bone marrow adipocyte progenitors express 498 
osterix (Osx), but not Grem1. Some marrow adipocytes are also derived from progenitors that 499 
express the leptin receptor (LepR). Based on these findings it is unclear if marrow adipocyte 500 
progenitors are endosteal and/or perivascular in origin, although they are clearly distinct to 501 
progenitors for white and brown adipocytes. Also unclear is how these progenitors are driven 502 
toward adipogenesis to generate bone marrow adipocytes, which can be classed as two distinct 503 
subtypes: regulated (rMAT) and constitutive (cMAT). Do these subtypes derive from distinct 504 
 19 
 
progenitors, and can rMAT and cMAT interconvert? In addition to physiological MAT formation, 505 
various conditions are associated with MAT loss or MAT expansion, predominantly in rMAT. 506 
However, the mechanisms linking these conditions to MAT loss or gain remain largely 507 
uncertain. (C) The function of MAT is also yet to be firmly established. Some reports suggest 508 
that MAT has BAT-like properties, though this remains controversial. Instead, MAT may have 509 
more WAT-like properties such as lipid storage and endocrine functions. It is now clear that 510 
MAT can release adipokines such as adiponectin and leptin, as well as paracrine factors such as 511 
cytokines and lipids. These secreted factors may allow MAT to exert both local and systemic 512 
effects on metabolic homeostasis, skeletal remodeling, hematopoiesis, and development of 513 
bone metastases. The diversity of these functions highlights the breadth of MAT’s potential 514 
impact on health and disease. 515 
Table 1. Changes in marrow adipose tissue in selected metabolic conditions 516 
  Human MAT Rodent MAT Ref 
Lipodystrophy 
CGL-1  Absent NA [2] 
CGL-2  Absent NA [2] 
CGL-3 Retained* Retained [2, 5] 
CGL-4 Retained* rMAT decreased, cMAT 
no change 
[2, 5] 
Diabetes 
Type 1 No change  Increased (tibia/femur) 
or no change (vertebrae) 
[40, 54] 
Type 2 Increase or No 
Change   
Increased [53, 55, 
56] 
Obesity/HFD Increase or No 
Change   
Increased [39, 57, 
58] 
Anorexia/CR Increased Increased [4, 12, 
38] 
Aging Increased Increased [5, 14] 
Estrogen 
Deficiency 
Increased Increased [66, 67] 
Glucocorticoi
ds 
Increased Increased [68, 69] 
CGL-X = Congenital Generalized Lipodystrophy where X represents the 
subtype of the disease, CR = Calorie Restriction, HFD = High Fat Diet, NA 
= Not Available, *Limited patient data available 
 517 
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 694 
Outstanding Questions Box 
Biology of the MAT adipocyte 
x What is the identity of the MAT progenitor(s)?  
x Do regulated and constitutive MAT adipocytes derive from distinct progenitors, or 
do they represent unique differentiation states within the same lineage? 
x Can regulated and constitutive MAT adipocytes interconvert?  
Physiology of MAT 
x What metabolites and endocrine factors does MAT secrete?  
x What are the metabolic implications of MAT’s endocrine action? 
x Does MAT have functionally significant BAT or beige-like adipocyte 
characteristics?  
x Can MAT serve as an energy source for hematopoietic or skeletal cells in some 
contexts? 
Pathology of MAT 
x Are certain types of MAT adipocytes more likely to have deleterious local or 
systemic effects? 
x Are all MAT-appearing cells within the bone marrow actually adipocytes? Can 
marrow lipid be acutely stored in non-MAT populations in some situations? 
x How is MAT expansion regulated in metabolic disease?  What are the 
implications? 
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